Post Reply
661-680 of 1050
Dear Readers,
I see this counter will reach to Sgd. 0.80 soon.
I just checked and saw the stock trading up nicely today, now at .745. If it trades up to.76 that's a sign that smart money wants to be invested before the earnings.
Hi Hulumas,
Hope you're correct. I'm vested.
Dear ZhouYu,
It is a matter of two month, be patient!
Hi Hulumas
Good stock with no good luck :(
Dear Readers,
I do not see any reason, why Bio-Treat will not protruding Sgd. 1.00 within two months!
-------------------------------------------------------------
Bio-Treat also said the next reset date for the conversion price of some $206 million worth of convertible bonds is Jan 18, 2007. The conversion price will be calculated by the average closing price for the 30 working days prior to the reset date, but cannot go below a floor of 91 cents.
------------------------------------------------------------
Someone asked what this means. The convertible bond has a floating conversion price which was at 1.02 and has now refixed to .91 It will not refix any further so there is no risk of further dilution. The 10% dilution from the current refix should have already been factored by any hedgers out there since the spot price was so far below .91. The refixing on Sept 06 from 1.20 to 1.02 caused roughly an additional 15% * 200 MM SGD of stock selling by hedge funds which is one reason the stock fell so sharply and since the refix is now done its also a reason the stock is on the rise now. Now it's an ordinary convertible bond which means there will be some hedge fund sellers as the stock moves higher, but there will be buyers as the stock moves lower going forward.
Ya, agree...
Even if you've attended a $6,000 training course, after the course, you would still prefer to have the instructor just simply tell you when to buy or sell.... :)
The simplest form I can think of for layman :)
SINGAPORE ? 18 January 2007 ? In a strategic move to grow its business, Bio-Treat
Technology Limited (?Bio-Treat? or ?The Company?), a biotechnology waste and
wastewater treatment specialist in the PRC, today announced a definitive agreement to
form a joint venture (?JV?) with All Praise Limited (?AP?), the business vehicle adopted
by Bio-Treat?s Japanese JV partners for entering into the JV agreement, to market an
innovative process technology for industrial wastewater treatment.
The new JV, called High Result Limited (?High Result?), will be 60 per cent owned by
Bio-Treat and 40% owned by AP. The total amount of Bio-Treat?s investment in this JV
which is RMB14.4 million, will be funded through internal resources.
Technology Limited (?Bio-Treat? or ?The Company?), a biotechnology waste and
wastewater treatment specialist in the PRC, today announced a definitive agreement to
form a joint venture (?JV?) with All Praise Limited (?AP?), the business vehicle adopted
by Bio-Treat?s Japanese JV partners for entering into the JV agreement, to market an
innovative process technology for industrial wastewater treatment.
The new JV, called High Result Limited (?High Result?), will be 60 per cent owned by
Bio-Treat and 40% owned by AP. The total amount of Bio-Treat?s investment in this JV
which is RMB14.4 million, will be funded through internal resources.
wastewater treatment specialist in the PRC, today announced a definitive agreement to
form a joint venture (?JV?) with All Praise Limited (?AP?), the business vehicle adopted
by Bio-Treat?s Japanese JV partners for entering into the JV agreement, to market an
innovative process technology for industrial wastewater treatment.
The new JV, called High Result Limited (?High Result?), will be 60 per cent owned by
Bio-Treat and 40% owned by AP. The total amount of Bio-Treat?s investment in this JV
which is RMB14.4 million, will be funded through internal resources.
by Bio-Treat?s Japanese JV partners for entering into the JV agreement, to market an
innovative process technology for industrial wastewater treatment.
The new JV, called High Result Limited (?High Result?), will be 60 per cent owned by
Bio-Treat and 40% owned by AP. The total amount of Bio-Treat?s investment in this JV
which is RMB14.4 million, will be funded through internal resources.
Bio-Treat and 40% owned by AP. The total amount of Bio-Treat?s investment in this JV
which is RMB14.4 million, will be funded through internal resources.
Bio-Treat Technology Limited
Page 2 of 5
High Result will combine the competitive advantages of Bio-Treat and its Japanese joint
venture partners to market, in the PRC, a unique physical/chemical process technology for
industrial wastewater treatment (the ?Japanese Technology?) invented by the Japanese
partners.
Utilizing the Japanese Technology, a proprietary blend of coagulant for wastewater
treatment under the Aqua-Mate brand, has been further invented by the Japanese partners.
This coagulant has been tested to be especially effective and efficient for treating complex
compositions of industrial wastewater such as that which involves colours, heavy metals,
and other toxic components. The Aqua-Mate coagulant also has the proven ability to
handle other treatment requirements which are difficult for the traditional coagulants to
handle.
Under the terms of the JV agreement, High Result will own the proprietary rights to both
the process technology and the coagulant formula. The PRC patent application to protect
the innovative process technology and the coagulant formula have been filed.
The JV will also take advantage of the competitive costs of production in the PRC to
establish a production facility in Dongguan City, the PRC to manufacture the coagulant.
The building of the production facility is expected to be completed before the end of
FY2007, and commencement of production will happen soon thereafter. At the new
production facility, High Result expects to manufacture 60,000 tons of coagulant per year.
The coagulant manufactured at this facility will be sold in the PRC as well as exported to
overseas markets, including Japan.
Bio-Treat has a highly successful track record in the secondary treatment wastewater
treatment process. With the Company?s access to the unique Japanese Technology for the
pre-treatment of wastewater through this joint venture, it will also be able to diversify the
scope of its business into two new areas ? Refractory Industrial Wastewater Treatment and
Water Recycling.
Bio-Treat?s Chief Executive Officer, Mr Dennis Chan said he was pleased with the latest
?step? Bio-Treat was taking in its drive to be a significant industry player.
?The formation of this JV builds extraordinary value for Bio-Treat. With the JV, we will
move into a new realm of our wastewater treatment business by extending our services to
Bio-Treat Technology Limited
Page 3 of 5
new areas in Refractory Industrial Wastewater Treatment and Water Recycling. Adding
another exciting dimension to the JV is the strategic access Bio-Treat will gain for the
expansion of our business in Japan. We intend to leverage on our rights to export the PRCproduced
coagulant to the Japanese market as an effective platform to expand our product
offerings to Japan.?
For a start, Bio-Treat plans to implement the Japanese Technology on its industrial and
municipal wastewater treatment projects for the primary stage or pre-treatment process
prior to subjecting the wastewater to the secondary stage of treatment using its own
proprietary BMS Biological Process Technology.
?By applying the unique combination of the Japanese Technology with our proprietary
BMS Biological Process Technology for treating wastewater, the output quality of the
treated water should be significantly improved, as compared to that which has been treated
by the other traditional forms of pre-treatment,? explained Mr Chan.
?We believe that the compelling value proposition of the Japanese Technology, the
proprietary coagulant, combined with the strength of our BMS Biological Process
Technology, will broaden Bio-Treat?s range of product applications to treat, in a more
effective and efficient manner, complex industrial wastewater. In short, it is a perfect
union of technologies, where the result is significantly greater than the sum of the parts.?
This ?union? places Bio-Treat in a stronger position than before to bid for large-scale
municipal projects, especially those that entail the treatment of high percentage of
industrial wastewater and those which its competitors are not able to treat, or cannot treat
to the required discharge standard of the Environmental Protection Agency in the PRC.
From a growth perspective, Mr Chan believes that the JV is expected to have a positive,
long-term impact on Bio-Treat due to the following reasons:
? New streams of recurring income generated through the new businesses of the joint
venture.
venture.
? Expected increases in volume of industrial wastewater treatment business due to
the application of the unique combination of the Japanese Technology with Bio-
Treat?s proprietary BMS Biological Process Technology on existing and future
projects.
the application of the unique combination of the Japanese Technology with Bio-
Treat?s proprietary BMS Biological Process Technology on existing and future
projects.
Bio-Treat Technology Limited
Page 4 of 5
? Increased volume of industrial wastewater treatment business translates to higher
profit margins for that business as industrial wastewater treatment, as compared to
domestic wastewater treatment, yields higher profit margins.
profit margins for that business as industrial wastewater treatment, as compared to
domestic wastewater treatment, yields higher profit margins.
? With this new Japanese Technology, Bio-Treat has the ability to take on
wastewater treatment projects that require a very specialized form of pre-treatment
due to pollutant complexity, especially in certain types of industrial wastewater.
wastewater treatment projects that require a very specialized form of pre-treatment
due to pollutant complexity, especially in certain types of industrial wastewater.
? Expected new project opportunities arising from utilizing the two technologies.
For instance, with this joint venture in place, Bio-Treat believes that it will be in a
good position to bid for recycling projects in the northern China region where
recycling of water is urgently needed.
?We are very excited about this new partnership. We believe the JV will generate strategic
and economic benefits to Bio-Treat through increased scope, new products and services,
tangible synergies and expansion into new geographic markets ? all the right reasons for a
JV. The JV is expected to expand the market for Bio-Treat and bring to market new and
advanced wastewater treatment solutions,? enthused Mr Chan.
For instance, with this joint venture in place, Bio-Treat believes that it will be in a
good position to bid for recycling projects in the northern China region where
recycling of water is urgently needed.
?We are very excited about this new partnership. We believe the JV will generate strategic
and economic benefits to Bio-Treat through increased scope, new products and services,
tangible synergies and expansion into new geographic markets ? all the right reasons for a
JV. The JV is expected to expand the market for Bio-Treat and bring to market new and
advanced wastewater treatment solutions,? enthused Mr Chan.